by Daykin, Tom Medcitynews.com
A start-up company formed by the founder of a Milwaukee-area drug ingredient maker is proposing to build a pharmaceutical research-and-development facility in Mequon, creating 50 jobs.
Major Pharmaceuticals LLC wants to develop a two-story, 79,000-square-foot facility on a 7.7-acre parcel immediately south of Executive Drive and east of Commerce St., according to a filing with the city Plan Commission. That site is in Mequon Business Park, near the northeast corner of W. Donges Bay and N. Wauwatosa roads.
The company, which will produce injectable serums, expects to complete the $10 million office and laboratory by late 2013, the filing said.
Major Pharmaceuticals will have an estimated 50 full-time employees, including 10 chemists and pharmacists, 15 lab quality-assurance technicians and 25 process operators. The commission was to review the proposal at its Monday night meeting.
The company was launched by Michael Major, according to state corporation records.
Major is the founder of Cambridge Major Laboratories Inc., a Germantown supplier of active pharmaceutical ingredients to the biotech and pharmaceutical industries.
In 2011, he announced his retirement as Cambridge Major’s chief executive officer but said he would remain as the company’s nonexecutive chairman and scientific adviser.
Major made the corporate filing for his new company on Dec. 28, according to state records.
That was one day after Cambridge Major said its majority owner, Arlington Capital Partners, had sold its entire stake in the firm to another private-equity partner, American Capital Ltd. of Bethesda, Md.
More related news in www.health-care-guide.com.